Ausgabe 1/2009
Inhalt (11 Artikel)
Antitumor activity of a novel EGFR tyrosine kinase inhibitor against human lung carcinoma in vitro and in vivo
Xishan Xiong, Lili Fu, Li Wang, Houan Cai, Lin Li, Hualiang Jiang, Wenhu Duan, Changlin Mei
Brazilian marine sponge Polymastia janeirensis induces apoptotic cell death in human U138MG glioma cell line, but not in a normal cell culture
Mario Luiz Conte da Frota Jr, Elizandra Braganhol, Andrés Delgado Canedo, Fabio Klamt, Miriam Anders Apel, Beatriz Mothes, Cléa Lerner, Ana Maria Oliveira Battastini, Amélia Teresinha Henriques, José Cláudio Fonseca Moreira
Effect of morin on tissue lipid peroxidation and antioxidant status in 1, 2-dimethylhydrazine induced experimental colon carcinogenesis
Vennila Sreedharan, Karthik Kumar Venkatachalam, Nalini Namasivayam
The effect of P-gp (Mdr1a/1b), BCRP (Bcrp1) and P-gp/BCRP inhibitors on the in vivo absorption, distribution, metabolism and excretion of imatinib
Roos L. Oostendorp, Tessa Buckle, Jos H. Beijnen, Olaf van Tellingen, Jan H. M. Schellens
Development of water soluble derivatives of cis-3, 4′, 5-trimethoxy-3′-aminostilbene for optimization and use in cancer therapy
David E. Durrant, Joanna Richards, Ashutosh Tripathi, Glen E. Kellogg, Paolo Marchetti, Marco Eleopra, Giuseppina Grisolia, Daniele Simoni, Ray M. Lee
A phase I study of bortezomib, etoposide and carboplatin in patients with advanced solid tumors refractory to standard therapy
Christopher Lieu, Laura Chow, A. Scott Pierson, S. Gail Eckhardt, Cindy L. O’Bryant, Mark Morrow, Zung Vu Tran, John J. Wright, Lia Gore
A phase I trial of PTK787/ZK222584 in combination with pemetrexed and cisplatin in patients with advanced solid tumors
Sunil Sharma, Burgess Freeman, Jeanette Turner, James Symanowski, Phillip Manno, William Berg, Nicholas Vogelzang
Docetaxel and epirubicin salvage regimen in relapsed anthracycline-sensitive metastatic breast cancer patients after anthracycline-containing adjuvant therapy
Jae Hong Seo, Hwa Jung Sung, Kyong Hwa Park, In Keun Choi, Sang Cheul Oh, Sang Won Shin, Yeul Hong Kim, Jun Suk Kim, Ae-Ree Kim, Jae-Bok Lee, Bum Hwan Koo
A phase II multicenter study of L-alanosine, a potent inhibitor of adenine biosynthesis, in patients with MTAP-deficient cancer
Hedy Lee Kindler, Howard A. Burris III, Alan B. Sandler, Ira Anton Oliff
Colonic pneumatosis and intestinal perforations with sunitinib treatment for renal cell carcinoma
Thomas W. Flaig, Fernando J. Kim, Francisco G. La Rosa, Kathryn Breaker, Jonathan Schoen, Paul D. Russ
Inhibition of protein synthesis by imexon reduces HIF-1α expression in normoxic and hypoxic pancreatic cancer cells
Betty K. Samulitis, Terry H. Landowski, Robert T. Dorr